Parkman Healthcare Partners LLC grew its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 37.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 651,625 shares of the company’s stock after buying an additional 178,313 shares during the quarter. Parkman Healthcare […]
Avoro Capital Advisors LLC lifted its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 65.2% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 4,222,222 shares of the company’s stock after acquiring an additional 1,666,667 shares during the quarter. Syndax Pharmaceuticals comprises approximately 1.3% of Avoro Capital Advisors LLC’s portfolio, making […]
Avoro Capital Advisors LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 2,858,888 shares of the biotechnology company’s stock after purchasing an additional 6,388 shares during the quarter. United Therapeutics comprises approximately 8.7% of Avoro Capital Advisors LLC’s […]
Personal CFO Solutions LLC boosted its position in shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP – Free Report) by 57.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 550,342 shares of the company’s stock after purchasing an additional 200,000 shares during the period. Personal CFO […]
Sectoral Asset Management Inc. cut its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 92.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,955 shares of the company’s stock after selling 167,240 shares during the quarter. Sectoral […]
Sectoral Asset Management Inc. cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 94.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,420 shares of the biopharmaceutical company’s stock after selling 116,260 shares during the period. Sectoral Asset Management Inc.’s holdings […]
Sectoral Asset Management Inc. reduced its position in Alkermes plc (NASDAQ:ALKS – Free Report) by 93.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,330 shares of the company’s stock after selling 228,930 shares during the period. Sectoral Asset […]
Sectoral Asset Management Inc. reduced its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 94.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 7,013 shares of the biopharmaceutical company’s stock after selling 111,290 shares during the quarter. Sectoral Asset Management Inc.’s holdings in Cytokinetics were worth $586,000 as of its most […]
Sectoral Asset Management Inc. lifted its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 10.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,445 shares of the company’s stock after buying an additional 410 shares during the period. Sectoral Asset Management […]
Sectoral Asset Management Inc. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 11.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 18,925 shares of the healthcare conglomerate’s stock after acquiring an additional 2,000 shares during the quarter. UnitedHealth […]